Abstract
Introduction
The acute release of radicals during reperfusion of the ischemic myocardium contributes to myocardial stunning w x 1,2 . Oxygen-derived radical species, including superoxide Ž yØ . anion O , are formed during reperfusion of the ischemic 2 heart and reach highest concentrations within the first w x yØ minute of reperfusion 3,4 . However, O requires trans-2 formation into more reactive oxidant species such as the hydroxyl radical in order to cause stunning, yet direct evidence for such pathways in the heart is lacking. Ž . The normal heart synthesizes nitric oxide NO from oxygen and L-arginine by a Ca 2q -dependent NO synthase which is present in the coronary endothelium, endocardial Ž endothelium, cardiac myocytes, and cardiac neurons see w x . Ref. 5 for review . The enzyme localized in vascular w x w x endothelium 6 and in the normal cardiac myocyte 7,8 Ž has been identified as the endothelial isoform eNOS or . NOS Type III . The physiological production of NO in the heart maintains coronary vasodilator tone, inhibits platelet aggregation and the adhesion of neutrophils and platelets Ž w x . to vascular endothelium see Ref. 9 for review . Morew x over, NO also exerts negative inotropic 10,11 and w x chronotropic 12 actions on the myocardium. Exposure of a diverse variety of cell types to endotoxin or pro-inflammatory cytokines leads to the expression of a Ca 2q -in-Ž . dependent NOS iNOS or NOS Type II which has also been found in the heart: in cardiac myocytes, coronary microvascular endothelial cells and in endocardial endothe-Ž w x . lial cells see Ref. 5 for review . The enhanced production of NO by Ca 2q -independent NOS contributes to the depression of myocardial contractile function following w x exposure to pro-inflammatory cytokines 13 .
The role of NO in myocardial ischemia and reperfusion injury is unclear. The conditions at reperfusion may be ideal for the release of excess quantities of NO in the heart. NO release may be stimulated through a number of Ž . mechanisms including: a the change in shear stress in the Ž . coronary vasculature during reperfusion, b enhanced 2q Ž . intracellular Ca levels as a result of ischemia, and c the thermodynamically favoured production of NO from L-arginine and molecular oxygen due to the reintroduction of oxygen. Ischemia stimulates an increase in NO formaw x tion in the heart 14-16 , and during reperfusion after controlled coronary hypoperfusion in dogs, its breakdown products in plasma, nitrite and nitrate, remain elevated w x 16 . Although the isoform of NOS responsible for these changes has not been identified, the rapid changes in NO production which occur within minutes during ischemia w x 2 q 2 q 14-16 suggest that Ca -dependent, and not Ca -independent, NOS is most likely involved. Inhibitors of NO synthase have been found to protect the heart against ischemia-reperfusion injury, both in vitro w x w x 17-21 and in vivo 22 . Indeed, in isolated working rabbit hearts subjected to global, no-flow ischemia we G Ž . have shown that N -monomethyl-L-arginine L-NMMA and N G -nitro-L-arginine methyl ester improved the recovw x ery of mechanical function during reperfusion 17 . The protective action of NOS inhibitor was reversed by Larginine, but not D-arginine, showing that its effect was w x due to competitive inhibition of NOS 17 . How inhibitors of NOS protect the heart from reperfusion injury is yet w x unclear as adenosine-dependent mechanisms 21 and imw x proved glucose metabolism during ischemia 19 have also w x been suggested. Paradoxically, NO donors 23 or the NOS w x substrate L-arginine 24 in concentrations which do not affect coronary vascular tone have also been shown to protect the heart from ischemia-reperfusion injury. . Radnoti Glass Technology, Monrovia, CA were purchased from the sources indicated. All other reagents used for perfusion were obtained from VWR Canlab or Sigma. Dityrosine was synthesized according to a published w x method 32 and its purity was verified by high-perforw x mance liquid chromatography 33 .
Methods

This investigation conforms with the
Preparation of peroxynitrite
Both ONOO y and decomposed ONOO y were prepared w x by the method described by Villa et Spontaneously beating hearts were used for these studies as we wanted to determine any potential consequences of changes in endogenous myocardial NO production on w x heart rate 12 . A small latex balloon connected to a pressure transducer was inserted through the left atrium and pushed through the mitral valve into the left ventricle. The balloon was filled with deionized water to achieve an end-diastolic pressure of 8-12 mmHg. The transducer was connected to a Grass polygraph recorder and heart rate and left ventricular pressure were monitored. Coronary flow Ž was measured by an in-line ultrasonic flow probe Trans-. onic positioned proximal to the perfusion cannula. During ischemia changes in left ventricular pressure were registered continuously. The time to onset of ischemic contracture was defined by a 4 mmHg increase above baseline in left ventricular pressure. The increase above left ventricular baseline pressure from the onset of ischemia to that determined at the end of ischemia was defined as the magnitude of ischemic contracture.
Measurement of dityrosine by fluorescence spectroscopy
Peroxynitrite has been shown to react with L-tyrosine in phosphate buffer at pH 6.0 to form a fluorescent product, w x dityrosine 31 . In order to check the sensitivity and linearity of this reaction in Krebs' buffer, a solution of L-tyro-Ž . sine 0.3 mM was prepared in Krebs' buffer which had Ž . been equilibrated with 95% O :5% CO pH 7.4 and was 2 2 y Ž . reacted with authentic ONOO 1-100 mM or an equivalent volume of decomposed ONOO y for 15 min at 378C. The formation of dityrosine was analyzed in the incubate Ž by measuring fluorescence spectra l s 320 nm and ex w x. l s 410 nm 31 at room temperature in a Shimadzu em RF 5000 spectrophotofluorometer. A sample from the same aliquot was then directly analyzed by high-perforw x mance liquid chromatography 33 to determine its dityrosine content. A time course study was performed by y Ž . addition of 10 mM ONOO to Krebs pH 7.4, 378C Ž . containing 0.3 mM L-tyrosine as above and after 1, 5, 15 or 30 min incubation, samples were measured for their dityrosine content by fluorescence spectroscopy. Further-Ž . more, solutions of authentic dityrosine 0.1-3.0 mM pre-Ž . pared in Krebs' buffer pH 7.4 showed a linear relation between fluorescence intensity and concentration using Ž 2 linear regression analysis r ) 0.999, n s 5, data not . shown . The detection limit for dityrosine was 0.05 mM. To determine whether SNAP had any effect on dityrosine fluorescence, it was added at 0.02 and 0.2 mM to standard Ž . solutions of dityrosine 0.1-3.0 mM in Krebs' buffer and fluorescence was measured.
Infusion of ONOO y
To determine whether this method could be used in the isolated heart, synthetic ONOO y was infused into aerobically perfused hearts perfused with Krebs' buffer at 378C containing 0.3 mM L-tyrosine. Following a 15 min period y Ž y . of equilibration, ONOO or decomposed ONOO was Ž infused into the aortic cannula via a sideport 50 ml over .
y 30 s such that the concentration of ONOO in the perfusate entering the heart was 10-150 mM. A 5 min period was allowed between each bolus infusion. Coronary effluent was collected at 15 s intervals up to 2 min from the start of infusion and kept on ice until it was analyzed for dityrosine by fluorescence spectroscopy.
Ischemia-reperfusion protocol
Hearts were subjected to an ischemia-reperfusion protocol which consisted of 25 min of aerobic perfusion, then 20 min of global, no-flow ischemia induced by clamping the aortic inflow line, and 30 min of aerobic reperfusion subsequent to reopening the clamp. The entire system was water-jacketed to maintain the temperature at 378C throughout the protocol. In additional series of hearts the following drugs were infused using a syringe infusion pump connected to the aortic side-arm cannula to give the Ž . Ž final concentrations as indicated: a L-NMMA 1-100 . mM infused during the final 10 min of aerobic perfusion Ž . and throughout the reperfusion, b superoxide dismutase Ž . Ž 50 Urml and catalase 50 Urml, to minimize possibility of hydrogen peroxide build-up by action of superoxide For all hearts a sample of coronary effluent was collected at 15 and 25 min during aerobic perfusion and at 30 s intervals for the first 2 min of reperfusion and then for 30 s intervals ending at 5, 15 and 30 min of reperfusion. The samples were placed on ice until the end of the experiment, allowed to return to room temperature, and dityrosine fluorescence was measured within 15 min.
Statistical analysis
Data were expressed as mean " s.e.m. of n experiments. Student's paired or unpaired t-test, or analysis of variance followed by Dunnett's test, were used to compare individual means. A value of P -0.05 was considered statistically significant.
Results
Detection of exogenous ONOO
y in the coronary effluent Ž . Ž . peroxide n s 3 or with the oxidation products of NO, Ž . nitrite or nitrate 300 mM, n s 3 for each for 15 min at Ž 378C did not cause the formation of dityrosine data not . shown .
The time course of reaction of 10 mM ONOO y with 0.3 mM L-tyrosine in Krebs' buffer is shown in Fig. 2 . The formation of dityrosine was very rapid as within 1 min of the addition of ONOO y the dityrosine level was already 69% of that seen at its plateau level which was reached by 15 min. Incubations of 30 min showed no further increase in dityrosine formation. We next determined whether L-tyrosine could be used as a detector for ONOO y formation, through the production of dityrosine, in the isolated, perfused heart preparation. Isolated rat hearts were perfused with Krebs' buffer Ž .
y supplemented with L-tyrosine 0.3 mM . Synthetic ONOO was infused through the aortic cannula to determine whether dityrosine could be detected in the coronary effluy w x ent. As ONOO is known to act as a vasodilator 29,34,35 and in order to verify the biological activity of our preparation of it, we found that infusion of synthetic ONOO y Ž . 10-150 mM as a 30 s bolus into the aortic cannula of the isolated heart caused a concentration-dependent increase in coronary flow which was rapid in onset and which returned to baseline within 2 min, whereas, in contrast, decomposed ONOO y was without effect. The baseline coronary flow was 11.5 " 0.4 mlrmin and peak flow during infusion of 10, 50 and 150 mM ONOO y was 14.0 " 1.0, 15.0 " 0.6, and 16.0 " 2.0 mlrmin, respec-Ž tively n s 3; P -0.05 versus baseline for 50 and 150 . y mM , whereas during infusion of decomposed ONOO Ž . diluted in an identical manner as above coronary flow was 13.0 " 0.0, 13.0 " 0.6, and 13.0 " 0.6 mlrmin, re-Ž . spectively n s 3, P ) 0.05 versus baseline . Fig. 3 shows Table 1 Effect of L-NMMA on coronary flow during aerobic perfusion in isolated rat hearts before or 10 min following infusion of L-NMMA the production of dityrosine as measured by its fluorescent signal in the coronary effluent collected during the bolus injection of ONOO y or decomposed ONOO y . In the concentration range of 10-150 mM ONOO y there was a rapid and concentration-dependent increase in dityrosine fluorescence which was maximal at 30-45 s following injection. In contrast, injection of decomposed ONOO y Ž . caused no change in dityrosine fluorescence Fig. 3 . 
Effect of L-NMMA on coronary flow during aerobic perfusion
As the basal release of NO in the coronary circulation w x contributes to its vasodilator tone 9 , we next determined the effect of the NO synthase inhibitor L-NMMA on baseline coronary flow. L-NMMA was infused in concentrations from 1-100 mM into aerobically perfused hearts beginning 10 min prior to the onset of ischemia. L-NMMA at 1 and 3 mM had no significant effect on coronary flow, whereas between 10-100 mM it caused a significant de-Ž . crease in baseline coronary flow Table 1 . L-NMMA Ž . 1-100 mM did not change either left ventricular devel-Ž oped pressure or heart rate during aerobic perfusion data . not shown .
Effect of L-NMMA on ischemic contracture
During ischemia in control hearts, the onset of ischemic contracture developed within 15.5 " 0.8 min from the start Ž .
Ž . Fig. 4 . Effects of L-NMMA on: A time to onset and B magnitude of ischemic contracture. Hearts were subjected to 25 min of aerobic perfusion followed by 20 min of global ischemia. Infusion of L-NMMA began 10 min prior to the onset of ischemia. ns6 hearts per group. ) P -0.05 versus control. 
Effect of L-NMMA on the recoÕery of mechanical function of reperfusion
Ž
. L -NMMA 10 mM, but not 1 or 100 mM caused a rapid and significant improvement in the recovery of post-Ž ischemic mechanical function heart rate = left ventricular . developed pressure product throughout the 30 min reper-Ž . fusion period compared to control hearts Fig. 5A . Measured at 30 min reperfusion, mechanical function was 10.9 " 1.4 and 3.0 " 1.5 mmHg = min y1 = 10 y3 in 10 mM L-NMMA perfused hearts and control hearts, respec-Ž . tively P -0.05 . This represents a recovery of 58 " 9 and 16 " 8% of preischemic values in L-NMMA-treated and Ž . control hearts, respectively P -0.05 . The recovery of mechanical function was due to a rapid and persistent Ž . improvement of both heart rate Fig. 5B and left ventricu-Ž . lar developed pressure Fig. 5C . Expressed as a percentage of pre-ischemic function, the recovery of mechanical function at 30 min reperfusion showed a bell-shaped, concentration-dependent protective action of L-NMMA Ž . with a maximum protective effect at 10 mM Fig. 6 . 
Detection of dityrosine at reperfusion and effect of L-NMMA
As L-NMMA is an inhibitor of NO formation, we examined its action on endogenous ONOO y formation during aerobic perfusion and reperfusion following ischemia. During aerobic perfusion, prior to the onset of ischemia, addition of L-NMMA had no effect on the Ž baseline fluorescence of the coronary effluent data not . shown . In control hearts, reperfusion caused the rapid increase in the generation of dityrosine in the coronary Ž effluent expressed as a percentage of its background level . measured in the same heart during aerobic perfusion to a Ž . maximum at 30 s of 167 " 14% P -0.002 which then Ž . declined to baseline values by 5 min reperfusion Fig. 7 and remained there until the end of the 30 min reperfusion 
Ž
. Ž . period data not shown . L-NMMA 1, 10, and 100 mM significantly inhibited the peak in the dityrosine signal seen at 30 s reperfusion to 119 " 5, 113 " 7, and 114 " 4% of baseline values, respectively, which was significant for Ž . all concentrations of L-NMMA P -0.05 . Fig. 8 shows the actions of superoxide dismutase 50 . Ž . U r ml and catalase 50 Urml , infused starting 5 min prior to the onset of ischemia and for the first 5 min of reperfusion, on ischemic contracture, recovery of mechanical function and dityrosine formation in ischemic-reperfused hearts. Catalase was added to prevent any possible detrimental actions of hydrogen peroxide formed by superoxide dismutase activity. The combination of superoxide dismutase and catalase did not reduce the time to onset or significantly alter the magnitude of ischemic contracture Ž . Fig. 8A , nor did it improve the recovery of mechanical Ž . function during reperfusion Fig. 8B . In contrast, upon reperfusion the formation of dityrosine in the coronary effluent was significantly reduced by superoxide dismutase Ž . and catalase Fig. 8C . 
Effects of superoxide dismutase and catalase Ž
Effects of exogenous NO by infusion of SNAP
The NO donor SNAP was infused at 0.02 and 0.2 mM into hearts 5 min prior to the onset of ischemia and for the first 5 min of reperfusion. At these concentrations, SNAP was without effect on coronary flow during the aerobic Ž . perfusion period prior to the onset of ischemia Table 2 . Moreover, these concentrations of SNAP had no effect on Ž . the fluorescence of authentic dityrosine Fig. 9 . As shown Table 2 Effect of SNAP on coronary flow during aerobic perfusion in isolated rat hearts before or 5 min following infusion of SNAP Ž . effluent see Fig. 7 legend for details . C or`denotes control hearts. ns6 hearts per group. ) P -0.05 vs. control.
in Fig. 10A , SNAP at both 0.02 and 0.2 mM significantly increased the time to onset and reduced the magnitude of Ž ischemic contracture. In contrast, SNAP at 0.2 mM but . not 0.02 mM significantly enhanced the recovery of postischemic mechanical function to 58 " 12% of pre-ischemic Ž . function, as measured at 30 min of reperfusion Fig. 10B . Infusion of SNAP inhibited the formation of dityrosine in the coronary effluent during reperfusion in a concentra-Ž . tion-dependent manner Fig. 10C . 
Discussion
Ischemia-reperfusion injury in the isolated rat heart resulted in the increased generation of dityrosine, which is cate that ONOO y was generated during the course of ischemia-reperfusion injury in the isolated heart. This is the first demonstration of the production of ONOO y in the intact organ. Whether ONOO y was generated during ischemia itself andror during the acute reperfusion cannot be ascertained; however, it would be expected that NO production should be greatly enhanced during acute reperfusion phase, at a time when O yØ levels greatly increase 2 w x y 3,4 . We also examined whether the generation of ONOO contributes to the development of mechanical dysfunction of the myocardium subjected to ischemia and reperfusion. In accordance with this hypothesis, we have recently observed a concentration and time-dependent depression of myocardial mechanical function in isolated rat hearts suby w x jected to the infusion of synthetic ONOO 35 . This was tested by examining the actions of L-NMMA, superoxide dismutase, and the NO donor SNAP on the development of this dysfunction and comparing this to their effects on ONOO y formation. We observed that L-NMMA caused a significant improvement in the recovery of mechanical function during reperfusion. This is in agreement with our previous observation that L-NMMA and N G -nitro-L-arginine methyl ester improved the recovery of mechanical function following global, no-flow ischemia in isolated working rabbit hearts, an effect which was specific to inhibition of NOS as the protection was abolished in the presence of excess Lw x arginine, but not D-arginine 17 . In the present study we examined the concentration-dependence of the protective action of L-NMMA and found optimal protection at 10 mM and then a loss of its protective action at higher concentrations, suggesting that partial inhibition of NO synthesis is required to protect the heart from myocardial stunning. Similar bell-shaped concentration-response relationships for inhibitors of NOS in preventing the consequences of excess production of NO during endotoxaemia w x 36 and during cytokine-mediated depression of cardiac w x mechanical function 13 have been observed. Therefore, it may be very important to select a concentration of NOS inhibitor which has minimal effect on physiological NO production, which is important for maintaining coronary w x vasodilator tone 37 , yet which reduces the excess release of NO, and consequently ONOO y , at reperfusion. Ž Interestingly, a higher concentration of L-NMMA 10 . mM was needed to improve the recovery of mechanical Ž . function of the heart than that 1 mM which caused similar inhibition of ONOO y generation, as measured by dityrosine formation. Measuring dityrosine in the coronary effluent likely greatly underestimates total myocardial y Ž . ONOO production at reperfusion because: a the low y w x reaction efficiency of ONOO with L-tyrosine 31 which Ž we estimate from our calibration experiments Fig. 1A and . Ž. y the vascular lumen; and c upon protonation ONOO will Ž react rapidly with a variety of intracellular targets i.e., . thiols, lipids and protein other than tyrosine. Moreover, w x the mitochondrial NOS 38 may have a differential sensitivity to inhibitory actions of L-NMMA than endothelial NOS found in the membrane and cytosolic fractions. Therefore, although 1 mM L-NMMA reduced the formation of dityrosine in the coronary effluent, we do not know whether the production of ONOO y throughout the heart was also significantly reduced. w x Ž Depre et al. 19 have shown that L-NMMA from 0.001 . to 10 mM, but not at 100 mM provided significant protection against ischemic injury in isolated rabbit hearts perfused at constant flow and subjected to low flow ischemia. Although Depre and colleagues concluded that thé protection afforded by L-NMMA may have been due to the enhancement of glycolysis during ischemia itself, they could not rule out a possible protective action of L-NMMA w x during early reperfusion 19 . Other mechanisms for the protective action of NOS inhibitors in myocardial ischemia w x and reperfusion could involve the release of adenosine 21 or may be attributable specifically to N G -nitro-L-arginine methyl ester when used at concentrations greater than 100 w x mM 20 , where this NOS inhibitor shows additional nonw x specific actions as a muscarinic receptor antagonist 40 . These other mechanisms, however, are unlikely in this study as we used L-NMMA which does not block musw x carinic receptors 40 . Moreover, in terms of blocking endothelial NOS, a concentration of 10 mM L-NMMA is comparable to 1 mM N G -nitro-L-arginine methyl ester w x 41 , which is 30 times lower than the concentration of N G -nitro-L-arginine methyl ester which was associated w x with an adenosine-dependent protective action 21 .
We have also examined the effects of removing O yØ by 2 superoxide dismutase. Catalase was added to prevent the possible detrimental actions of H O produced as a result 2 2 of superoxide dismutase activity. This combination failed to improve the recovery of mechanical function of the heart, although it inhibited the formation of dityrosine in the coronary effluent, similar to the results with 1 mM L-NMMA. The short time course of application of superoxide dismutase and its inability to reach the intracellular w x compartment 42 are consistent with the notion that it was able to reduce the extracellular concentration of O yØ , and 2 therefore ONOO y , without significantly affecting the intracellular generation of ONOO y . In accordance with this notion, we have recently observed in this same model of ischemia and reperfusion that a low molecular weight w x mimetic of superoxide dismutase 43 which readily penetrates the intracellular compartment improved the recovery of mechanical function to a similar extent to that of 10 mM w x L-NMMA 44 .
Infusion of the NO donor SNAP, in concentrations which did not affect coronary flow, also caused a concentration-dependent improvement in the recovery of mechanical function following ischemia and reperfusion. NO w x w x donors 23 and L-arginine 17,24 have been shown to be protective in models of ischemia and reperfusion injury, both in vivo and in vitro, although the mechanism by which this occurs is unclear. In vivo, it is likely that NO-mediated prevention of neutrophil adhesion to the vascular wall andror platelet activation may become im-Ž . portant especially in the later hours stages of reperfusion w x 45 . However, concentration-dependent protection by NO and NO donor compounds of the acute deleterious effects of ONOO y and other free radicals have been observed in w x w x w x the coronary circulation 29 , platelets 27 , fibroblasts 30 w x and lipid membranes 28 . Moreover, infusion of SNAP reduced the formation of dityrosine from ONOO y released at reperfusion. This effect of SNAP was not due to quench-Ž . ing dityrosine fluorescence Fig. 9 , but may have been a result of the reaction of NO with tyrosyl radical intermedi-Ž ates which are produced during exposure of L-tyrosine y w x. with ONOO 46 as opposed to tyrosyl radicals combining together to form dityrosine. The protection by NO donors and L-arginine in the setting of myocardial reperfusion may be due to the ability of NO to terminate y w x ONOO -mediated lipid radical chain propagation 28 , decrease elevated cytosolic Ca 2q levels by stimulating w x y cyclic GMP production 47 , or prevent ONOO -mediated impairment of endothelium-dependent vasodilation in the w x coronary circulation 29 .
Ž . The isoform s of NOS responsible for the rapid increase in NO production in the heart during ischemia and reperfusion is unknown. Although we can only speculate, the rapid increase in L-NMMA-inhibitable dityrosine production at reperfusion is likely a consequence of the Ca the isolated heart. Indeed, rapid changes in NO production have been shown to occur within minutes of the onset of w x ischemia 14-16 . We have previously observed that the freshly isolated rat heart possesses only Ca 2q -dependent NOS activity and requires at least 2 h exposure in vitro to endotoxin andror pro-inflammatory cytokines before inducible NOS activity is measurable in the myocardium w x 7,13 .
An increase in NO by-products have been observed in the coronary sinus blood of patients following cross-clamp w x release during cardiac by-pass surgery 48 and in piglet w x hearts subjected to hypoxia-reoxygenation injury 49 . We speculate that the use of NOS inhibitors at low concentrations to limit the production of ONOO y which may occur during the acute reperfusion phase following thrombolytic therapy or after cardioplegia during cardiac surgery may only be necessary and prudent during the first minutes of reperfusion. After this time it is likely that provision of Ž . L -arginine to reverse the action of the NOS inhibitor andror NO donors would be of benefit due to the cardio-Ž . protective vasodilator, anti-neutrophil and anti-platelet actions of NO.
In summary, we have demonstrated that myocardial ischemia and reperfusion results in the generation of ONOO y , an effect that was prevented by inhibition of NOS, removing O yØ , or by the provision of low amounts 2 of exogenous NO. Our results also indicate that the formation of ONOO y at reperfusion may contribute to the development of mechanical dysfunction of the heart. Whether the generation of ONOO y is a generalized phenomenon affecting various regional vascular beds as a result of ischemia-reperfusion injury remains to be studied.
